Lindbrook Capital, LLC - ROCKET PHARMACEUTICALS INC ownership

ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 174 filers reported holding ROCKET PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 2.61 and the average weighting 0.4%.

Quarter-by-quarter ownership
Lindbrook Capital, LLC ownership history of ROCKET PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$3,750
+114.4%
183
+108.0%
0.00%
Q2 2023$1,749
+16.1%
880.0%0.00%
Q1 2023$1,507
-12.5%
880.0%0.00%
Q4 2022$1,722
+72.2%
880.0%0.00%
Q3 2022$1,0000.0%880.0%0.00%
Q2 2022$1,000
-90.0%
88
-62.7%
0.00%
-100.0%
Q1 2021$10,000
-88.6%
236
-85.2%
0.00%
-90.9%
Q4 2020$88,000
+125.6%
1,600
-5.9%
0.02%
+100.0%
Q3 2020$39,000
+85.7%
1,700
+13.3%
0.01%
+37.5%
Q1 2020$21,000
-38.2%
1,5000.0%0.01%
-33.3%
Q4 2019$34,000
-2.9%
1,500
-50.0%
0.01%
-7.7%
Q3 2019$35,000
+133.3%
3,000
+200.0%
0.01%
+116.7%
Q2 2019$15,000
+114.3%
1,000
+100.0%
0.01%
+100.0%
Q4 2018$7,0005000.00%
Other shareholders
ROCKET PHARMACEUTICALS INC shareholders Q1 2021
NameSharesValueWeighting ↓
M28 Capital Management LP 715,880$11,354,00010.44%
RTW INVESTMENTS, LP 15,802,802$250,632,0005.19%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 63,000$17,884,0004.03%
TANG CAPITAL MANAGEMENT LLC 1,265,900$20,077,0004.02%
Prosight Management, LP 203,268$3,224,0002.08%
COWEN AND COMPANY, LLC 1,000,000$15,860,0001.53%
Boxer Capital, LLC 1,466,051$23,252,0001.20%
Cormorant Asset Management, LP 868,550$13,775,0001.06%
Amitell Capital Pte Ltd 97,331$1,544,0000.90%
SECTORAL ASSET MANAGEMENT INC 303,975$4,821,0000.86%
View complete list of ROCKET PHARMACEUTICALS INC shareholders